Professional Documents
Culture Documents
Print Able Beers Pocket Card
Print Able Beers Pocket Card
AGS BEERS CRITERIA TABLE 1: 2012 AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
Organ System/ Recommendation, Rationale,
FOR POTENTIALLY INAPPROPRIATE Therapeutic Category/Drug(s) Quality of Evidence (QE) & Strength of Recommendation (SR)
Antispasmodics Avoid except in short-term palliative care to decrease
MEDICATION USE IN OLDER ADULTS n Belladonna alkaloids oral secretions.
n Clidinium-chlordiazepoxide
FROM THE AMERICAN GERIATRICS SOCIETY n Dicyclomine Highly anticholinergic, uncertain effectiveness.
n Hyoscyamine
This clinical tool, based on The AGS 2012 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older n Propantheline QE = Moderate; SR = Strong
Adults (AGS 2012 Beers Criteria), has been developed to assist healthcare providers in improving medication safety in n Scopolamine
older adults. Our purpose is to inform clinical decision-making concerning the prescribing of medications for older
adults in order to improve safety and quality of care. Antithrombotics
Dipyridamole, oral short-acting* (does not Avoid.
Originally conceived of in 1991 by the late Mark Beers, MD, a geriatrician, the Beers Criteria catalogues medications apply to the extended-release combination with May cause orthostatic hypotension; more effective alternatives
that cause adverse drug events in older adults due to their pharmacologic properties and the physiologic changes of aspirin) available; IV form acceptable for use in cardiac stress testing.
aging. In 2011, the AGS undertook an update of the criteria, assembling a team of experts and funding the develop- QE = Moderate; SR = Strong
ment of the AGS 2012 Beers Criteria using an enhanced, evidence-based methodology. Each criterion is rated (qual- Ticlopidine* Avoid.
ity of evidence and strength of evidence) using the American College of Physicians’ Guideline Grading System, which Safer, effective alternatives available.
is based on the GRADE scheme developed by Guyatt et al. QE = Moderate; SR = Strong
The full document together with accompanying resources can be viewed online at www.americangeriatrics.org. Anti-infective
Nitrofurantoin Avoid for long-term suppression; avoid in patients with
INTENDED USE CrCl <60 mL/min.
The goal of this clinical tool is to improve care of older adults by reducing their exposure to Potentially Inappropri- Potential for pulmonary toxicity; safer alternatives available; lack of
ate Medications (PIMs). efficacy in patients with CrCl <60 mL/min due to inadequate drug
n This should be viewed as a guide for identifying medications for which the risks of use in older adults outweigh concentration in the urine.
the benefits. QE = Moderate; SR = Strong
n These criteria are not meant to be applied in a punitive manner.
n This list is not meant to supersede clinical judgment or an individual patient’s values and needs. Prescribing and Cardiovascular
managing disease conditions should be individualized and involve shared decision-making. Alpha1 blockers Avoid use as an antihypertensive.
n These criteria also underscore the importance of using a team approach to prescribing and the use of non- n Doxazosin High risk of orthostatic hypotension; not recommended as routine
n Prazosin treatment for hypertension; alternative agents have superior risk/
pharmacological approaches and of having economic and organizational incentives for this type of model.
n Implicit criteria such as the STOPP/START criteria and Medication Appropriateness Index should be used in n Terazosin benefit profile.
a complementary manner with the 2012 AGS Beers Criteria to guide clinicians in making decisions about safe QE = Moderate; SR = Strong
medication use in older adults. Alpha agonists Avoid clonidine as a first-line antihypertensive. Avoid oth-
n Clonidine ers as listed.
The criteria are not applicable in all circumstances (eg, patient’s receiving palliative and hospice care). If a clinician is n Guanabenz* High risk of adverse CNS effects; may cause bradycardia and
not able to find an alternative and chooses to continue to use a drug on this list in an individual patient, designation n Guanfacine* orthostatic hypotension; not recommended as routine treatment
of the medication as potentially inappropriate can serve as a reminder for close monitoring so that the potential for n Methyldopa* for hypertension.
an adverse drug effect can be incorporated into the medical record and prevented or detected early. n Reserpine (>0.1 mg/day)* QE = Low; SR = Strong
Antiarrhythmic drugs (Class Ia, Ic, III) Avoid antiarrhythmic drugs as first-line treatment of atrial
n Amiodarone fibrillation.
TABLE 1: 2012 AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults n Dofetilide
n Dronedarone Data suggest that rate control yields better balance of benefits and
Organ System/ Recommendation, Rationale,
n Flecainide harms than rhythm control for most older adults.
Therapeutic Category/Drug(s) Quality of Evidence (QE) & Strength of Recommendation (SR)
n Ibutilide
Anticholinergics (excludes TCAs) n Procainamide Amiodarone is associated with multiple toxicities, including thyroid
First-generation antihistamines (as single Avoid. n Propafenone disease, pulmonary disorders, and QT interval prolongation.
agent or as part of combination products) n Quinidine QE = High; SR = Strong
n Brompheniramine Highly anticholinergic; clearance reduced with advanced age, and n Sotalol
n Carbinoxamine tolerance develops when used as hypnotic; increased risk of confu- Disopyramide* Avoid.
n Chlorpheniramine sion, dry mouth, constipation, and other anticholinergic effects/ Disopyramide is a potent negative inotrope and therefore may
n Clemastine toxicity. induce heart failure in older adults; strongly anticholinergic; other
n Cyproheptadine antiarrhythmic drugs preferred.
n Dexbrompheniramine Use of diphenhydramine in special situations such as acute treat- QE = Low; SR = Strong
n Dexchlorpheniramine ment of severe allergic reaction may be appropriate.
n Diphenhydramine (oral)
Dronedarone Avoid in patients with permanent atrial fibrillation or
heart failure.
n Doxylamine QE = High (Hydroxyzine and Promethazine), Moderate (All others); SR
n Hydroxyzine = Strong Worse outcomes have been reported in patients taking drone-
n Promethazine
n Triprolidine
darone who have permanent atrial fibrillation or heart failure. In
general, rate control is preferred over rhythm control for atrial
Antiparkinson agents Avoid. fibrillation.
n Benztropine (oral) QE = Moderate; SR = Strong
n Trihexyphenidyl Not recommended for prevention of extrapyramidal symptoms Digoxin >0.125 mg/day Avoid.
with antipsychotics; more effective agents available for treatment of In heart failure, higher dosages associated with no additional
Parkinson disease. benefit and may increase risk of toxicity; decreased renal clearance
may increase risk of toxicity.
QE = Moderate; SR = Strong QE = Moderate; SR = Strong
Anticholinergics/antispasmodics (see online Increased risk of bleeding compared with warfarin in adults ≥75 years old; lack of
for full list of drugs with strong anticholinergic evidence for efficacy and safety in patients with CrCl <30 mL/min
properties) QE = Moderate; SR = Weak
n Antipsychotics Prasugrel Use with caution in adults ≥75 years old.
n Belladonna alkaloids
n Clidinium-chlordiazepoxide Greater risk of bleeding in older adults; risk may be offset by benefit in highest-
n Dicyclomine risk older patients (eg, those with prior myocardial infarction or diabetes).
n Hyoscyamine QE = Moderate; SR = Weak
n Propantheline
n Scopolamine
Antipsychotics Use with caution.
n Tertiary TCAs (amitriptyline, clomip-
Carbamazepine
Carboplatin May exacerbate or cause SIADH or hyponatremia; need to monitor sodium level
ramine, doxepin, imipramine, and trimip- Cisplatin closely when starting or changing dosages in older adults due to increased risk.
ramine) Mirtazapine
History of Aspirin (>325 mg/day) Avoid unless other alternatives are not ef- SNRIs QE = Moderate; SR = Strong
gastric or Non–COX-2 selective NSAIDs fective and patient can take gastroprotective SSRIs
duodenal agent (proton-pump inhibitor or misoprostol). TCAs
ulcers Vincristine
May exacerbate existing ulcers or cause new/addi- Vasodilators Use with caution.
tional ulcers.
QE = Moderate; SR = Strong May exacerbate episodes of syncope in individuals with history of syncope.
Kidney/Urinary Tract QE = Moderate; SR = Weak
Chronic kid- NSAIDs Avoid. Table 3 Abbreviations: CrCl, creatinine clearance; SIADH, syndrome of inappropriate antidiuretic hormone
ney disease secretion; SSRIs, selective serotonin reuptake inhibitors; SNRIs, serotonin–norepinephrine reuptake inhibitors;
stages IV May increase risk of kidney injury. SR, Strength of Recommendation; TCAs, tricyclic antidepressants; QE, Quality of Evidence
and V
Triamterene (alone or in combination) May increase risk of acute kidney injury.
The American Geriatrics Society gratefully acknowledges the support of the John A. Hartford Foundation,
QE = Moderate (NSAIDs), Low (Triamterene); SR = Strong Retirement Research Foundation and Robert Wood Johnson Foundation.
(NSAIDs),Weak (Triamterene)
AGS
Urinary Estrogen oral and transdermal (excludes Avoid in women.
incontinence intravaginal estrogen) THE AMERICAN GERIATRICS SOCIETY 40 Fulton Street, 18th Floor
(all types) in Aggravation of incontinence. Geriatrics Health Professionals. New York, NY 10038
women 800-247-4779 ot 212-308-1414
Leading change. Improving care for older adults. www.americangeriatrics.org
QE = High; SR = Strong